Bottom line
Is HFSIX a good fund? The bottom line
HFSIX is the Class I share class of Hartford Schroders International Contrarian Value Fund, an actively managed international stock mutual fund from Hartford.
Annual fees run 0.85% — about $85 a year on every $10,000 invested, cheaper than 56% of international stock funds we track.
With $246 million in net assets and 52 holdings, its largest position is State Street Global Advisors (2.8%) and the top 10 make up 25.4% of the portfolio.
What stands out
- No front-end sales load
Updated Nov 19, 2026
What HFSIX invests in
The Fund seeks long-term capital appreciation.
Under normal circumstances, the Fund invests at least 65% of its net assets in equity securities of foreign issuers, including non-U.S. dollar denominated securities and securities of emerging market issuers. The Funds sub-advisers, Schroder Investment Management North America Inc. (SIMNA) and Schroder Investment Management North America Limited (SIMNA Ltd., together with SIMNA, the Sub-Advisers), use a contrarian value approach to select securities for the Fund. The Sub-Advisers use proprietary quantitative screening tools to narrow the opportunity set and then perform fundamental analysis to identify securities that they believe are significantly undervalued relative to their long-term earnings potential. The Sub-Advisers seek to invest in companies that they believe have favorable long-term prospects but are temporarily out of favor with investors. A company may be out of favor for…
From the fund's prospectus (filed Feb 26, 2026).
What HFSIX costs
On a $10,000 investment, HFSIX's 0.85% expense ratio costs about $85 a year. The prospectus estimates $1,254 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
HFSIX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | State Street Global Advisors | 2.77% |
| 2 | Randstad NV | 2.71% |
| 3 | ABN AMRO Bank NV | 2.70% |
| 4 | Societe Generale SA | 2.65% |
| 5 | Gsk Plc | 2.63% |
| 6 | Sanofi SA | 2.61% |
| 7 | Evonik Industries AG | 2.49% |
| 8 | Henkel AG & Co KGaA | 2.38% |
| 9 | Reckitt Benckiser Group PLC | 2.26% |
| 10 | Dentsu Group Inc | 2.17% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 25.4% of the fund. See all top 25 holdings and asset mix →